Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer

ALL RIGHT. WHAT HAPPENED TO THE STOCK IN NOVO NORDISK. THE DANISH DRUG COMPANY, YOU KNOW, IS THE INVENTOR OF OZEMPIC AND WEGOVY.LAST WEEK, THEY REPORTED A BEAT AND RAISE QUARTER. YET THE STOCK FELL NEARLY 6% THE DAY THOSE NUMBERS WERE RELEASED. SINCE THEN, WELL, IT MADE UP MOST OF ITS LOSSES, BUT THAT WAS A STUNNING REACTION.HEY, KEEP IN MIND, NOVO NORDISK HELPED INVENT THE GLP ONE CATEGORY, AND THEIR OBESITY AND DIABETES BUSINESSES ARE NOW PRINTING MONEY. IN JANUARY, THEY LAUNCHED A PILL VERSION OF WEGO ...